Shubham Misra: CCL2 As a Potential Biomaker for Post-Stroke Seizures, Epileptiform Discharges and Mortality
Shubham Misra, Postdoctoral Associate at Yale Department of Neurology, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Our latest study, published in PLOS One, identifies the role of CCL2 as a potential biomarker associated with late seizures and epileptiform discharges (SED) and 90-day mortality post SED in ICH patients.”
Title: Characterizing inflammatory biomarkers in post-stroke seizure risk and outcome prognostication
Authors: Ethan Y. Wang, Shubham Misra, Jennifer Yan, Pei Yi Chook, Yuki Kawamura, Rachel Kitagawa, Jennifer A. Kim, Emily J. Gilmore, Adam de Havenon, Adithya Sivaraju, Lawrence J. Hirsch, Guido J. Falcone, Srikant Rangaraju, Lauren H. Sansing, Jessica Magid-Bernstein, Nishant K. Mishra
Read the Full Article on PLOS One

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series